196 related articles for article (PubMed ID: 18052078)
1. Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.
Papp E; Tse JK; Ho H; Wang S; Shaw D; Lee S; Barnett J; Swinney DC; Bradshaw JM
Biochemistry; 2007 Dec; 46(51):15103-14. PubMed ID: 18052078
[TBL] [Abstract][Full Text] [Related]
2. Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates.
Li M; Luraghi P; Amour A; Qian XD; Carter PS; Clark CJ; Deakin A; Denyer J; Hobbs CI; Surby M; Patel VK; Schaefer EM
Anal Biochem; 2009 Jan; 384(1):56-67. PubMed ID: 18762159
[TBL] [Abstract][Full Text] [Related]
3. Identification of BCAR-1 as a new substrate of Syk tyrosine kinase through a determination of amino acid sequence preferences surrounding the substrate tyrosine residue.
Kim JY; Huh K; Jung R; Kim TJ
Immunol Lett; 2011 Mar; 135(1-2):151-7. PubMed ID: 21047529
[TBL] [Abstract][Full Text] [Related]
4. Structural and biophysical characterization of the Syk activation switch.
Grädler U; Schwarz D; Dresing V; Musil D; Bomke J; Frech M; Greiner H; Jäkel S; Rysiok T; Müller-Pompalla D; Wegener A
J Mol Biol; 2013 Jan; 425(2):309-33. PubMed ID: 23154170
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of the Syk activation switch.
Tsang E; Giannetti AM; Shaw D; Dinh M; Tse JK; Gandhi S; Ho H; Wang S; Papp E; Bradshaw JM
J Biol Chem; 2008 Nov; 283(47):32650-9. PubMed ID: 18818202
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic prospect of Syk inhibitors.
Ruzza P; Biondi B; Calderan A
Expert Opin Ther Pat; 2009 Oct; 19(10):1361-76. PubMed ID: 19670961
[TBL] [Abstract][Full Text] [Related]
7. Purification of catalytic domain of rat spleen p72syk kinase and its phosphorylation and activation by protein kinase C.
Borowski P; Heiland M; Kornetzky L; Medem S; Laufs R
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):649-57. PubMed ID: 9531509
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
Hawkins J; Marcy A
Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
[TBL] [Abstract][Full Text] [Related]
9. A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition.
Lipchik AM; Killins RL; Geahlen RL; Parker LL
Biochemistry; 2012 Sep; 51(38):7515-24. PubMed ID: 22920457
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: a review.
Kaur M; Singh M; Silakari O
Eur J Med Chem; 2013 Sep; 67():434-46. PubMed ID: 23917087
[TBL] [Abstract][Full Text] [Related]
11. Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.
Dinh M; Grunberger D; Ho H; Tsing SY; Shaw D; Lee S; Barnett J; Hill RJ; Swinney DC; Bradshaw JM
J Biol Chem; 2007 Mar; 282(12):8768-76. PubMed ID: 17264076
[TBL] [Abstract][Full Text] [Related]
12. Activation of spleen tyrosine kinase (Syk) at fertilization in Rhinella arenarum eggs.
Mouguelar VS; Coux G
Int J Dev Biol; 2014; 58(10-12):811-8. PubMed ID: 26154322
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors.
Hirabayashi A; Mukaiyama H; Kobayashi H; Shiohara H; Nakayama S; Ozawa M; Tsuji E; Miyazawa K; Misawa K; Ohnota H; Isaji M
Bioorg Med Chem; 2008 Oct; 16(20):9247-60. PubMed ID: 18823784
[TBL] [Abstract][Full Text] [Related]
14. Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors.
Choi JS; Hwang HJ; Kim SW; Lee BI; Lee J; Song HJ; Koh JS; Kim JH; Lee PH
Bioorg Med Chem Lett; 2015 Oct; 25(20):4441-6. PubMed ID: 26384287
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput fluoroimmunoassay for Syk kinase and Syk kinase inhibitors.
Yamamoto N; Hasegawa H; Seki H; Ziegelbauer K; Yasuda T
Anal Biochem; 2003 Apr; 315(2):256-61. PubMed ID: 12689835
[TBL] [Abstract][Full Text] [Related]
16. Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays.
Singh D; Rani R; Rajendran R; Kaur NJ; Pandey A; Chopra P; Jain T; Jain MK; Grover S; Arya R; Saini KS
Biotechnol J; 2010 Feb; 5(2):201-12. PubMed ID: 20013945
[TBL] [Abstract][Full Text] [Related]
17. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
[TBL] [Abstract][Full Text] [Related]
18. Complex phosphorylation dynamics control the composition of the Syk interactome in B cells.
Bohnenberger H; Oellerich T; Engelke M; Hsiao HH; Urlaub H; Wienands J
Eur J Immunol; 2011 Jun; 41(6):1550-62. PubMed ID: 21469132
[TBL] [Abstract][Full Text] [Related]
19. Getting Syk: spleen tyrosine kinase as a therapeutic target.
Geahlen RL
Trends Pharmacol Sci; 2014 Aug; 35(8):414-22. PubMed ID: 24975478
[TBL] [Abstract][Full Text] [Related]
20. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
